JONES DAY TALKS®: The CNPV Pilot Program – FDA’s High-Speed Lane for Drug Approval

About this episode

This episode discusses the CNPV Pilot Program and its impact on drug approval times.

In one of the most aggressive regulatory shake-ups in modern pharmaceutical history, the Commissioner’s National Priority Voucher Pilot Program, or CNPV, can dramatically reduce approval times for new drug introductions. Jones Day’s Jessica Tierney and Melissa Mannion explain how the program works and what potential applicants need to know.

People in this episode

Host: Jones Day

Guests: Jessica Tierney, Melissa Mannion

Topics covered

• drug approval
• pharmaceutical regulation
• CNPV Pilot Program
• healthcare
• government policy

Keywords

• CNPV
• drug approval
• FDA
• pharmaceuticals
• regulatory changes

Mentioned in this episode

Organizations: FDA

More episodes of Jones Day Talks

• JONES DAY TALKS®: Why Clients Need a Global Class Actions Defence Team · May 12, 2026 · 35 min
• JONES DAY TALKS®: A View from the Inside: A Conversation with Koch’s Nick Hoffman on the State of the Venture Market · April 28, 2026 · 29 min
• JONES DAY TALKS®: Perspectives and Pathways Conference Delivers Career Guidance to Top Law School Talent · April 8, 2026 · 32 min
• JONES DAY TALKS®: Women in IP – Supreme Court Denies Review of Thaler v. Perlmutter: AI Authorship Questions Remain · March 17, 2026 · 30 min
• JONES DAY TALKS®: Perspectives and Pathways: Becoming a Lawyer and Building Your Professional Brand · January 27, 2026 · 32 min
• JONES DAY TALKS®: Real Assets Roundup – Episode 6: Higher Education · December 8, 2025 · 31 min